ID
41999
Description
Study ID: 104507 Clinical Study ID: BEX104507 Study Title: Phase II Study of Iodine-131 Anti-B1 Antibody for Non Hodgkin’s Lymphoma Patients who have Previously Received Rituximab Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00996593 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: tositumomab Trade Name: Bexxar Study Indication: Lymphoma, Non-Hodgkin
Mots-clés
Versions (3)
- 23/07/2018 23/07/2018 -
- 18/08/2018 18/08/2018 -
- 15/03/2021 15/03/2021 - Dr. rer. medic Philipp Neuhaus
Détendeur de droits
GlaxoSmithKline
Téléchargé le
15 mars 2021
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 3.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Iodine-131 Anti-B1 Antibody for Non Hodgkin’s Lymphomas NCT00996593
Concomitant Medications and Transfusions and Adverse Experiences
- StudyEvent: ODM
Description
Concomitant Medications and Transfusions
Alias
- UMLS CUI-1
- C4284232
- UMLS CUI-2
- C0521115
- UMLS CUI-3
- C1879316
- UMLS CUI-4
- C0521115
Description
Drug or Blood Product
Type de données
text
Alias
- UMLS CUI [1]
- C0013227
- UMLS CUI [2]
- C0456388
Description
Drug or Blood Product Dose
Type de données
text
Alias
- UMLS CUI [1,1]
- C0013227
- UMLS CUI [1,2]
- C0178602
- UMLS CUI [2,1]
- C0456388
- UMLS CUI [2,2]
- C0178602
Description
Drug or Blood Product Dose Unit
Type de données
text
Alias
- UMLS CUI [1,1]
- C0013227
- UMLS CUI [1,2]
- C0178602
- UMLS CUI [1,3]
- C0439148
- UMLS CUI [2,1]
- C0456388
- UMLS CUI [2,2]
- C0178602
- UMLS CUI [2,3]
- C0439148
Description
Route of drug administration
Type de données
text
Alias
- UMLS CUI [1]
- C0013153
Description
Medication frequency | Transfusion (procedure); Frequencies (time pattern)
Type de données
text
Alias
- UMLS CUI [1]
- C3476109
- UMLS CUI [2,1]
- C1879316
- UMLS CUI [2,2]
- C0439603
Description
Date treatment started
Type de données
date
Alias
- UMLS CUI [1]
- C3173309
Description
Date treatment stopped
Type de données
date
Alias
- UMLS CUI [1]
- C1531784
Description
continuing therapy
Type de données
text
Alias
- UMLS CUI [1]
- C1553904
Description
Adverse Experiences
Alias
- UMLS CUI-1
- C0877248
Description
Adverse Experiences
Alias
- UMLS CUI-1
- C0877248
Description
adverse event; Numbers
Type de données
integer
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0237753
Description
Adverse event
Type de données
text
Alias
- UMLS CUI [1]
- C0877248
Description
Adverse Event Grade Code
Type de données
text
Alias
- UMLS CUI [1]
- C2985911
Description
Serious: Fatal or immediately life- threatening, permanently disabling, requires of prolongs hospitalization, or congenital anomaly.
Type de données
boolean
Alias
- UMLS CUI [1]
- C1519255
Description
Adverse Event Onset Date
Type de données
date
Alias
- UMLS CUI [1]
- C2985916
Description
Adverse event; End Date
Type de données
date
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0806020
Description
Adverse event; Continuous
Type de données
text
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0549178
Description
Adverse event; Frequencies (time pattern)
Type de données
text
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0439603
Description
Pharmaceutical Preparations; Therapeutic procedure; Measures
Type de données
text
Alias
- UMLS CUI [1,1]
- C0013227
- UMLS CUI [1,2]
- C0087111
- UMLS CUI [1,3]
- C0079809
Description
Record all that apply
Type de données
text
Alias
- UMLS CUI [1,1]
- C0087111
- UMLS CUI [1,2]
- C0079809
- UMLS CUI [1,3]
- C0205394
Description
Therapeutic procedure; Measures; Other; Specification
Type de données
text
Alias
- UMLS CUI [1,1]
- C0087111
- UMLS CUI [1,2]
- C0079809
- UMLS CUI [1,3]
- C0205394
- UMLS CUI [1,4]
- C2348235
Description
Adverse Event Outcome
Type de données
text
Alias
- UMLS CUI [1]
- C1705586
Description
Adverse event; Pharmaceutical Preparations; Relationships
Type de données
text
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0013227
- UMLS CUI [1,3]
- C0439849
Description
Adverse event; Disease; Relationships
Type de données
text
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0012634
- UMLS CUI [1,3]
- C0439849
Description
Investigator Signature
Alias
- UMLS CUI-1
- C2346576
Similar models
Concomitant Medications and Transfusions and Adverse Experiences
- StudyEvent: ODM
C1704732 (UMLS CUI [1,2])
C1517741 (UMLS CUI [1,2])
C0521115 (UMLS CUI-2)
C1879316 (UMLS CUI-3)
C0521115 (UMLS CUI-4)
C0456388 (UMLS CUI [2])
C0178602 (UMLS CUI [1,2])
C0456388 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0178602 (UMLS CUI [1,2])
C0439148 (UMLS CUI [1,3])
C0456388 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0439148 (UMLS CUI [2,3])
C1879316 (UMLS CUI [2,1])
C0439603 (UMLS CUI [2,2])
C0237753 (UMLS CUI [1,2])
C0806020 (UMLS CUI [1,2])
C0549178 (UMLS CUI [1,2])
C0439603 (UMLS CUI [1,2])
C0087111 (UMLS CUI [1,2])
C0079809 (UMLS CUI [1,3])
C0079809 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,3])
C0079809 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,3])
C2348235 (UMLS CUI [1,4])
C0013227 (UMLS CUI [1,2])
C0439849 (UMLS CUI [1,3])
C0012634 (UMLS CUI [1,2])
C0439849 (UMLS CUI [1,3])